Claritic

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Claritic

Claritic is a prescription-only medicine containing the active ingredient Clarithromycin, fundamentally classified as a Macrolide Antibiotic used to manage bacterial infections.

Property Description
Active ingredient Clarithromycin
Form Oral Tablet, Oral Suspension
Pharmacological class Macrolide Antibiotic
Common use Fighting systemic bacterial infections
Origin Semi-synthetic

What Type of Medicine is Claritic?

Claritic is a powerful Antibacterial Agent designated as a Macrolide Antibiotic, a classification that establishes its primary function is to address systemic illness caused by susceptible pathogenic microorganisms. The active compound, Clarithromycin, is semi-synthetic, meaning it is chemically derived and optimized from the natural macrolide, Erythromycin. Its efficacy is clinically recognized by the medical community for managing a broad spectrum of bacterial pathogens. The macrolide class is recognized for its high utility in treating various infections where this class of antibiotic is appropriate.


Composition and Available Forms of Claritic

The single active component in this product is Clarithromycin, which is combined with inactive pharmaceutical excipients to create stable preparations. Claritic is prepared for systemic use, requiring oral administration to be absorbed into the bloodstream. It is typically supplied as an oral tablet or as granules for oral suspension. This dual availability is a key differentiating factor, as the suspension allows for tailored dosing, making the medication especially suitable for pediatric patients who may have difficulty swallowing solid forms. Macrolides are frequently listed as essential medicines due to their demonstrated effectiveness and multiple dosage forms, aiding patient adherence.


How Claritic Provides General Benefit to the Body

The general benefit of Claritic is its ability to fight and neutralize systemic bacterial infections by effectively halting the proliferation of harmful bacteria. Its high-level mechanism involves acting as a protein synthesis inhibitor, binding to the bacteria's internal ribosomes and thereby preventing them from manufacturing the proteins essential for their growth and replication. By blocking bacterial growth, Claritic eliminates the primary cause of the illness, allowing the body's natural defenses to resolve the infection. The medicine is commonly used in scenarios requiring the elimination of bacterial pathogens susceptible to macrolides.

Regulatory References

  1. NIH Macrolide Review

What side effects are possible with Claritic?

Possible Side Effects and Safety Information

The safety profile of Claritic (Clarithromycin) is formally documented in government regulatory materials and classified according to the systems affected and the frequency of occurrence.

Adverse reactions are organized into System-Organ Classes, covering effects on the Gastrointestinal System, Nervous System, Hepato-biliary System, and Cardiac System, among others.

Commonly documented adverse reactions (ge 1/100) include abdominal pain, diarrhea, nausea, vomiting, headache, insomnia, and dysgeusia (taste perversion). Uncommon reactions (ge 1/1,000) may involve palpitations, vertigo, and elevated liver enzymes.

Documented Serious Adverse Reactions

Regulatory labels specify several critical, though rare, safety concerns. These include QT prolongation and life-threatening ventricular arrhythmias, such as Torsades de Pointes. Cases of fatal hepatic failure have been reported, particularly in individuals with pre-existing liver disease. Other serious reactions noted are severe acute hypersensitivity reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and Clostridioides difficile-associated Diarrhea (CDAD).

Population-Specific Safety Considerations

The official safety information addresses specific patient populations. It notes that the medicine is contraindicated in patients with severe hepatic failure combined with renal impairment. Furthermore, official regulatory documents note a long-term risk concern for increased all-cause mortality observed years after treatment in patients with established Coronary Heart Disease.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Claritic (Clarithromycin) is primarily associated with exaggerated gastrointestinal disturbances, including severe abdominal pain, nausea, vomiting, and diarrhea. Official regulatory documents emphasize that overdose carries a risk of serious, life-threatening systemic outcomes. These include cardiac arrhythmias, such as QT interval prolongation and Torsades de pointes, and the potential for fatal hepatic failure. Confusion and disorientation have also been reported in severe cases.

Immediate medical attention is mandated if a substantially higher dose than prescribed has been ingested or if specific life-threatening signs are present, such as collapse, seizure, trouble breathing, or inability to be awakened. Urgent contact with emergency services is required under these circumstances.

Management is symptomatic and supportive, as no specific antidote is known for Clarithromycin overdose. Procedures such as gastric lavage may be considered. Due to the confirmed cardiac risk, immediate ECG monitoring is required, along with laboratory monitoring of hepatic and renal function. Special consideration is noted for elderly patients and individuals with renal impairment, who may be more susceptible to cardiotoxicity and severe drug interactions.

Therapeutic Uses of Claritic

What Claritic Treats: Main Uses and Benefits

Claritic is commonly used for the supportive management of various distressing symptoms that interfere with daily functioning. The medicine provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during periods of heightened symptomatic distress. Claritic is commonly used for the temporary relief of symptoms associated with hay fever or other **upper respiratory allergies.


Key Areas of Use

This medication is relevant for conditions involving episodic or fluctuating manifestations where symptoms may appear abruptly or cluster into disruptive patterns. It is considered relevant for easing symptoms such as sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat. In general clinical scenarios, Claritic is applied when short-term symptomatic assistance is needed to help the patient cope more steadily with symptom fluctuations.

“Claritic may assist with maintaining functional stability and supports the patient during episodes of heightened discomfort by easing distress.”


Quick Fact

Quick Fact: Relevant for Symptomatic Discomfort


Symptomatic Relief for Acute Discomfort

Claritic is generally used when a patient experiences sudden, intensified discomfort or symptoms associated with acute or episodic changes. The medicine offers support that helps ease the overall symptom burden, particularly during periods of heightened symptoms that create noticeable physiological strain and interfere with routine activities.

Regulatory References

  1. DailyMed drug label published by the National Library of Medicine

Eligibility and Restrictions for Use

Who can and cannot use Claritic?

This section summarizes the official eligibility information for Claritic (loratadine) strictly based on governmental regulatory documents.


Populations for Whom Use is Contraindicated

The medicine is contraindicated and must not be used by individuals who have a known hypersensitivity or history of an allergic reaction to loratadine or to any other ingredients contained within the product formulation.

Age-Related Eligibility

Age Group Eligibility Status (General)
Children under 2 years of age Use not established and not recommended (requires doctor's consultation)
Children 2 to under 6 years of age Consult a doctor (use generally restricted to oral solution forms)
Individuals 6 years of age and older Generally permitted for use as directed by the label

Conditional Use Requiring Doctor's Advice

Individuals with pre-existing liver disease (hepatic impairment) or kidney disease (renal impairment) must consult a doctor before using Claritic. Use is considered conditional for these groups, as official labeling notes that their condition may necessitate a lower or modified dose.

Physiological and Specific Condition Restrictions

Condition Eligibility Status
Pregnancy and Breastfeeding Consult a health professional before use
Phenylketonuria (PKU) Caution advised, as some formulations (e.g., chewable tablets) contain phenylalanine

Regulatory documents establish these clear restrictions based on allergic status, age, organ function, and physiological state to define who can and who must not take the medicine.

What should I know about interactions with other medicines?

Claritic Interactions with Other Medicines and Products

Official regulatory information emphasizes that the primary risk associated with Claritic (Clarithromycin) is its potent ability to increase the systemic exposure of other co-administered medicinal products.


Formally Contraindicated Combinations

Regulatory authorities strictly prohibit the co-administration of Claritic with the following substances due to the risk of serious or fatal toxicity:

  • Astemizole, Cisapride, Domperidone, Pimozide, Terfenadine: Contraindicated due to risk of QT prolongation and serious cardiac arrhythmias, including Torsades de Pointes.
  • Lovastatin and Simvastatin: Contraindicated due to substantially increased plasma concentrations, increasing the risk of rhabdomyolysis.
  • Ergot Alkaloids (e.g., Ergotamine): Contraindicated due to risk of acute ergot toxicity.
  • Oral Midazolam, Lomitapide, Lurasidone, Ticagrelor, Ivabradine, Ranolazine.

Documented Pharmacokinetic Effects

Claritic is officially classified as a strong inhibitor of the CYP3A4 enzyme and the P-glycoprotein (P-gp) transporter. This is the documented basis for many Exposure-Modifying Interactions that increase the concentration of affected drugs (e.g., Digoxin, Warfarin, Carbamazepine). Concomitant use with Warfarin requires close monitoring of the International Normalized Ratio (INR).


Population-Specific Constraints

The co-administration of Colchicine with Claritic is specifically contraindicated in patients with pre-existing renal or hepatic impairment, as this combination carries a high risk of fatal toxicity. The use of Extended-Release (ER) formulations is subject to a regulatory requirement to be taken with food to maintain proper absorption.

Mechanism of Action

How Claritic Works

Clarithromycin's mechanism is defined by its selective, reversible binding to the 50S ribosomal subunit of susceptible bacteria, specifically engaging the 23S ribosomal RNA. This interaction positions the drug at the exit tunnel, functioning as an inhibitor that physically obstructs the process of translocation.

By blocking translocation, Clarithromycin prevents the elongation of the polypeptide chain, which is the crucial step in protein synthesis. The functional cellular consequence is bacteriostasis, meaning the mechanism halts the growth and replication of the bacterium. This action causes a subsequent reduction in the active bacterial load, modulating the overall microbial population. The mechanism is constrained by bacterial resistance factors such as ribosomal methylation, which alters the 50S binding site, and efflux pumps that actively prevent the molecule from reaching its intracellular target in sufficient concentration.

Dosage and Administration Information

How to Use Claritic

Claritic, which contains the active ingredient Clarithromycin, is administered through two primary routes: oral (using tablets or suspension) and intravenous (IV) infusion. The IV route is typically reserved for hospitalized patients and is generally transitioned to oral therapy within two to five days. The total duration of a complete course of therapy is typically 7 to 14 days.


Administration Forms and Regimens

The way Claritic is taken depends on the specific pharmaceutical form. Immediate-Release (IR) tablets and the oral suspension are usually administered twice daily (every 12 hours) and may be taken with or without food. In contrast, the Extended-Release (ER) tablet is administered once daily as a 1000 mg dose (two 500 mg tablets) and must be taken with food to ensure correct absorption. The ER tablets must be swallowed whole and should not be crushed or chewed.


Use in Specific Populations and Conditions

For children over six months of age, the oral suspension is the recommended form, with the dosage calculated based on the child's weight at 15 mg/kg/day divided every 12 hours. For patients with severe renal impairment (creatinine clearance less than 30 mL/min), the dosage must be reduced by one-half of the standard recommended dose. Intravenous administration requires the drug to be diluted and infused slowly over 60 minutes; it must not be given as a rapid injection.

Recent Clinical Evidence

Evidence for Use in Systemic Bacterial Infections

Claritic was studied for managing systemic infections caused by susceptible bacteria, primarily through short-term Randomized Controlled Trials (RCTs). These studies examined outcomes related to systemic or functional imbalance, such as changes related to fever or observed activity level, and microbiological status. The findings describe patterns observed in the studies showing how clinical endpoints evolved in the study populations. This evidence contributes to understanding symptom patterns over the short-term, but it is important to remember that these findings describe group patterns, not personal outcomes.


How Claritic was Studied Against Other Treatments and Placebo

Claritic was evaluated in comparative trials against inactive treatments (placebo) or other commonly used antibiotics. These studies monitored specific variables, including measured outcomes related to physical discomfort. The research explored these comparisons to understand the observed patterns. Data show patterns related to the observed rates of measured clinical endpoints when Claritic was associated with certain patterns compared to other treatments, providing context for the medicine’s clinical evaluation.


Long-Term Research and Durability of Observed Effects

Most primary clinical research for Claritic focused on the immediate treatment period, meaning follow-up durations were limited in many key studies. As a result, long-term effects are not fully established, and there is limited information regarding the maintenance of observed changes after the course of treatment concludes. The evidence base remains focused on research exploring short-term symptom changes rather than sustained wellness over longer periods.


Evidence in Different Patient Populations and Research Gaps

Research was observed in groups beyond the general adult population, including pediatric patients and trial subsets involving those with conditions marked by functional limitations (comorbidities). Data for certain groups remain insufficient when compared to the general adult population. For highly specialized uses, the findings showed statistical heterogeneity across different studies. Research is ongoing to address how increasing global antimicrobial resistance patterns may influence outcomes. Overall, the available evidence highlights what is known — and what is still uncertain — and does not predict the specific individual outcome based on the group patterns reported in the trials.

Key Studies & References

  1. Macrolide Antibiotics: A Review of Clinical Efficacy and Safety (NIH Bookshelf)
  2. NLM DailyMed: Official Drug Label and Information for Clarithromycin

Frequently Asked Questions (FAQ)

Common questions about Claritic (FAQ)

Q: Are there any specific foods or drinks that should be avoided while taking Claritic?

Regulatory guidance on the use of Claritic indicates that the immediate-release form can generally be taken with or without food. However, official product information specifies that the Extended-Release form must be taken with food to ensure correct absorption. Regulatory product information notes that alcohol is generally permitted.

Q: Can Claritic affect blood pressure or heart rate?

The official safety profile notes that certain side effects related to heart function are documented as possible, such as palpitations (feeling your heart beat fast or irregular) as an uncommon reaction. Furthermore, a serious, though rare, cardiac risk includes QT prolongation. General effects on blood pressure are not cited as common or uncommon adverse reactions in the regulatory documentation.

Q: Does Claritic contain any common allergens, like lactose or gluten?

Regulatory documents state that some commercial formulations of clarithromycin contain lactose as an inactive ingredient. The presence of specific allergens like gluten or other excipients depends on the exact type of tablet or suspension and its manufacturer. Official labeling always provides a complete list of all ingredients, both active and inactive.

Q: Do research trials on Claritic use placebos, and what does that mean?

Studies used to examine Claritic were comparative trials that involved an inactive treatment, known as a placebo. In research, a placebo is a substance with no active drug used to help determine if the observed patient outcomes are directly due to the medicine or to other non-drug factors. This comparative method is standard practice in clinical research.

Q: Is it true that Claritic is part of a newer generation of medicine?

The active component of Claritic, Clarithromycin, is officially described as a semi-synthetic macrolide antibiotic. It is a chemically modified version of the older, naturally occurring macrolide Erythromycin. This chemical optimization places it in the classification of a second-generation macrolide.

Q: Is Claritic linked to any effects on mood or mental clarity?

Official regulatory documents list several central nervous system effects among the possible side effects of Claritic. These include headache, insomnia, and dizziness, as well as less common reactions like anxiety, confusion, and nightmares. This information highlights patterns observed in study populations.

Q: Is Claritic the same kind of medicine as other treatments for this condition?

Claritic is officially classified as a Macrolide Antibiotic, which defines its mechanism of action. This pharmacological classification distinguishes it from other major classes of antibacterial agents, such as penicillins or tetracyclines. The drug is used specifically to manage infections caused by susceptible pathogens.

Q: Is Claritic classified as a controlled substance?

According to regulatory classifications in the United States and similar international bodies, Claritic's active ingredient, clarithromycin, is an antibiotic. It is not classified as a controlled substance. However, it is a prescription-only medicine.

Q: Does Claritic cause fatigue or drowsiness?

Official product information lists central nervous system effects such as dizziness and insomnia (difficulty sleeping). While specific, general terms like fatigue or drowsiness are not typically listed among the most common adverse reactions, these effects may be considered within the scope of documented CNS reactions.

Q: What is the purpose of the 'inactive ingredients' listed in Claritic's packaging?

Official documents define inactive ingredients, or excipients, as substances combined with the active drug. Their purpose is to ensure the medicine remains stable and safe for its shelf life, to aid in the drug's absorption into the body, or to improve the product's appearance or taste.

Q: Is Claritic safe to take with common pain relievers like ibuprofen or acetaminophen?

The interactions section of the regulatory label focuses primarily on drugs with formal contraindications, such as certain heart medications or statins. Common non-prescription pain relievers like ibuprofen or acetaminophen are typically not listed in the formal contraindications section.

Q: What should I do if I accidentally miss taking a dose of Claritic?

Official guidance instructs that a missed dose is generally taken as soon as the patient remembers. If it is almost time for the next scheduled dose, the missed dose should be skipped. The guidance also specifies that it is not recommended to take two doses to compensate for a single missed dose.

Q: Are there any known interactions between Claritic and supplements, like vitamins or herbs?

Regulatory documents emphasize the risk of interaction with other medicines, but they also cite specific herbal supplements, such as St. John’s Wort, as potentially affecting the drug's metabolism. No formal major interactions are commonly listed for general vitamins.

Q: Is Claritic known to interact with birth control pills?

Regulatory documents contain information suggesting that antibiotics in this class may affect how the body processes the hormones in some oral contraceptives, such as increasing their blood levels. Conversely, official warnings for some hormonal birth control products caution that antibiotics may reduce the contraceptive's effectiveness.

Q: Why is Claritic sometimes used in combination with other treatments?

Official product indications explicitly state that Claritic is designed to be used in combination with other anti-microbial agents or medicines like proton pump inhibitors for certain infections. Specific uses include the management of infections caused by H. pylori (peptic ulcer disease) and Mycobacterium avium complex (MAC).

Q: Does Claritic have a risk of dependence or withdrawal symptoms?

Official safety sections focus on documenting all known and expected adverse reactions. Drug dependence, abuse potential, or the occurrence of a formal withdrawal syndrome are not listed as known risks or adverse reactions associated with the use of Claritic.

Q: Can taking Claritic make someone more sensitive to sunlight?

Official regulatory documents list photophobia (an increased sensitivity to light) as an uncommon adverse reaction associated with Claritic. Patients should be aware of this possibility, as is standard with documented side effects.

Q: Are there documented cases where Claritic interacts with alcohol?

According to official guidance from healthcare authorities, alcohol is generally permitted while undergoing a course of Claritic. No formal or major pharmacokinetic interaction between the drug and alcohol is documented in regulatory product information.

Q: What is the difference between Claritic's mechanism and that of older drug classes?

The mechanism of Claritic is defined by its selective binding to the bacterial 50S ribosome to stop protein synthesis. This action is distinct from older antibiotic classes, such as the penicillins, whose mechanisms involve targeting the bacterial cell wall structure instead.

Q: What happens if I stop taking Claritic suddenly?

Regulatory instructions emphasize the importance of completing the full prescribed course of Claritic treatment. Official guidance advises that premature cessation is associated with the risk of the infection returning and may contribute to antibiotic resistance.

Q: Are there official warnings about operating machinery while on Claritic?

Official regulatory text outlines information regarding the need for caution during activities that require full concentration. Patients should be aware of possible side effects like dizziness, vertigo, confusion, and hallucinations before deciding to drive or operate complex machinery.

Q: What should I know about taking Claritic if I have diabetes?

Official regulatory warnings note that taking Claritic with certain other medicines, including some used to treat diabetes (like disopyramide), can increase the risk of hypoglycemia (low blood sugar). For this reason, official guidance may require blood glucose levels to be closely monitored when the medicines are used together.

Q: How does the official guidance describe the need for follow-up appointments when using Claritic?

Official guidance emphasizes the need for close follow-up and monitoring in specific patient groups. This includes individuals taking drugs with narrow therapeutic windows (like Warfarin, which requires INR monitoring) and those with pre-existing conditions, such as heart disease or hepatic or renal impairment.

Q: Can Claritic affect my ability to drive?

Official regulatory documents provide information regarding the potential effects on driving ability. This is because certain documented side effects, including dizziness, vertigo, confusion, or disorientation, could impair one's ability to drive safely.

Q: Is Claritic only for severe cases of the condition it treats?

Official indications state that Claritic is intended for the treatment of mild-to-moderate infections caused by susceptible bacteria. It is not reserved exclusively for severe cases and is also indicated for specific complex conditions when used in combination with other drugs.

Q: Why is the official dosage range for Claritic sometimes described as flexible?

The official dosage range for Claritic is described by regulatory bodies as being dependent on several factors. These include the specific type of infection being treated, the pharmaceutical form (e.g., immediate-release versus extended-release), and required adjustments for patients with severe kidney impairment.

How should Claritic be stored and disposed of?

Storage and Disposal Rules for Claritic (Clarithromycin)

Formulation Mandatory Storage Conditions
Oral Tablets Store at 20 C to 25 C (68 F to 77 F). Protect from light, moisture, and excess heat. Keep container tightly closed.
Oral Suspension Store at Room Temperature (15 C to 30 C). Do not refrigerate or freeze. Discard unused portion after 14 days from mixing.

All forms of Claritic must be stored out of the reach of children. Unused or expired medication should generally not be flushed down the sink or toilet. Official disposal guidelines recommend mixing the product with an undesirable substance, such as dirt or used coffee grounds, placing the mixture in a sealed container, and then discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Claritic found in:

A-Z Index: